WHO R&D roadmaps

The R&D roadmaps encompass basic research through to late-stage development, licensure and early use of products. Each roadmap will serve as a collaborative framework to underpin strategic goals and research priority areas so as to accelerate the development of diagnostics, therapeutics and vaccines to prevent and control severe emerging diseases due to priority pathogens.

 A coordinated global research roadmap is available for:

• COVID-19

 Roadmaps are fully developed for:

• Ebola and Marburg (among the filoviral diseases)

• Crimean-Congo haemorrhagic fever and Lassa fever (among the Arenaviral haemorrhagic fevers)

• Nipah

Development of roadmaps are underway for:

• Zika

• Rift Valley Fever

• Pathogen X